Fatty liver ultrasound study for MAFLD
Part of Digestive system clinical trials.
This trial is testing a new ultrasound method to measure fat in the liver for people with metabolic fatty liver disease (MAFLD). It may help understand how well ultrasound can show liver fat compared to a liver biopsy or MRI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are Chinese and between 18 and 85 years old.
- A routine ultrasound showed fat in your liver (diffuse or patchy).
- You have MAFLD, meaning you have liver fat plus overweight (BMI 23 or higher), type 2 diabetes, or at least two metabolic risk factors (like high waist size, high blood pressure, or abnormal cholesterol).
- You are planning to get a liver biopsy or special MRI (MRI-PDFF) within the next week to measure liver fat.
- Your blood test shows low bleeding risk (platelets over 50 and INR under 1.5).
- You agree to join and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new method that uses sound waves to measure fat in your liver. It could help doctors check liver health without a biopsy.
This study tests a new ultrasound device that uses sound waves to measure fat in the liver without needles or surgery. It is for people with a type of fatty liver disease called MASLD or MASH, who are already getting an MRI to check their liver.
This study uses a special ultrasound device called FibroScan to check for fatty liver disease (MASLD) in people with obesity who are planning to have weight-loss surgery. The results will be compared to a liver biopsy to see how well the device works.
This trial compares a new ultrasound technique to a standard MRI scan for measuring liver fat. It may help improve how we diagnose and monitor fatty liver disease.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study is testing a new ultrasound method to measure fat in the liver. It is for people who may have a liver condition or have risk factors like diabetes or obesity, as well as healthy volunteers.
Hear when a new Fatty Liver Disease, Nonalcoholic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.